AF
IMVT icon

Amalgamated Financial’s Immunovant IMVT Stock Holding History

Amalgamated Financial’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$33K Buy
+5,943
New +$37K ﹤0.01% 2588

Other funds holding IMVT

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Amalgamated Financial's IMVT Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Immunovant (IMVT) in Q1 2022: 5,943 shares worth $33K. The stake represents ﹤0.01% of the portfolio and ranks #2588 among its holdings.

112 funds tracked by Wall St. Rank hold IMVT as of Q1 2022.

  • Amalgamated Financial held 5,943 shares of Immunovant worth $33K as of Q1 2022.
  • Immunovant was a new Amalgamated Financial position in Q1 2022.
  • Immunovant made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2588 holding.
  • 112 funds tracked by Wall St. Rank held Immunovant as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.